Henry Schein, Inc. (HSIC) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $84.78 (-1.90%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 20, 2026 | Steven Valiquette | Mizuho Securities | $81.00 | -4.5% |
| Jul 14, 2025 | Michael Cherny | Leerink Partners | $75.00 | -11.5% |
| May 6, 2025 | Michael Petusky | Barrington | $86.00 | +1.4% |
| Oct 15, 2024 | Daniel Rich | CFRA | $67.00 | -21.0% |
| Oct 8, 2024 | Elizabeth Anderson | Evercore ISI | $74.00 | -12.7% |
| Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $92.00 | +8.5% |
| Nov 13, 2023 | Jonathan Block | Stifel Nicolaus | $70.00 | -17.4% |
| Jun 17, 2022 | Jonathan Block | Stifel Nicolaus | $80.00 | -5.6% |
| Jun 14, 2022 | Jeff Johnson | Robert W. Baird | $88.00 | +3.8% |
| Aug 4, 2021 | Steven Valiquette | Barclays | $82.00 | -3.3% |
Top Analysts Covering HSIC
HSIC vs Sector & Market
| Metric | HSIC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.45 | 2.25 | 2.41 |
| Analyst Count | 11 | 8 | 19 |
| Target Upside | +12.6% | +153002.0% | +21.5% |
| P/E Ratio | 25.61 | 3.45 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-27 | $13.67B | $13.71B | $13.75B | 13 |
| 2027-03-27 | $3.44B | $3.46B | $3.48B | 5 |
| 2027-06-27 | $3.48B | $3.49B | $3.51B | 5 |
| 2027-09-27 | $3.57B | $3.58B | $3.60B | 6 |
| 2027-12-27 | $3.67B | $3.69B | $3.71B | 9 |
| 2028-03-27 | $3.69B | $3.71B | $3.73B | 4 |
| 2028-06-27 | $3.72B | $3.74B | $3.76B | 4 |
| 2028-09-27 | $3.82B | $3.84B | $3.86B | 6 |
| 2028-12-27 | $3.94B | $3.96B | $3.98B | 9 |
| 2029-12-27 | $15.22B | $15.30B | $15.38B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-27 | $5.27 | $5.32 | $5.37 | 11 |
| 2027-03-27 | $1.35 | $1.36 | $1.37 | 10 |
| 2027-06-27 | $1.35 | $1.36 | $1.37 | 10 |
| 2027-09-27 | $1.54 | $1.55 | $1.56 | 10 |
| 2027-12-27 | $1.56 | $1.57 | $1.58 | 10 |
| 2028-03-27 | $1.62 | $1.63 | $1.64 | 6 |
| 2028-06-27 | $1.59 | $1.61 | $1.62 | 6 |
| 2028-09-27 | $1.83 | $1.85 | $1.86 | 6 |
| 2028-12-27 | $1.79 | $1.80 | $1.81 | 6 |
| 2029-12-27 | $6.75 | $6.80 | $6.85 | 2 |
Frequently Asked Questions
What is the analyst consensus for HSIC?
The consensus among 11 analysts covering Henry Schein, Inc. (HSIC) is Buy with an average price target of $92.33.
What is the highest price target for HSIC?
The highest price target for HSIC is $92.00, set by Jeff Johnson at Robert W. Baird on 2024-07-22.
What is the lowest price target for HSIC?
The lowest price target for HSIC is $67.00, set by Daniel Rich at CFRA on 2024-10-15.
How many analysts cover HSIC?
11 analysts have issued ratings for Henry Schein, Inc. in the past 12 months.
Is HSIC a buy or sell right now?
Based on 11 analyst ratings, HSIC has a consensus rating of Buy (2.45/5) with a +12.6% upside to the consensus target of $92.33.
What are the earnings estimates for HSIC?
Analysts estimate HSIC will report EPS of $5.32 for the period ending 2026-12-27, with revenue estimated at $13.71B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.